You can find the annual or quarterly income statement of Pelthos Therapeutics Ord Shs here for insights into the performance and operational efficiency of Pelthos Therapeutics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total revenue

--7.41M

Revenue

--7.41M

Cost of revenue

--3.00M

Operating expenses

--22.77M

R&D expenses

--145.00K

Depreciation, depletion, and amortization

--1.07M

Operating profit

---15.36M

Net non-operating interest income (expenses)

Non-operating interest expense

--1.35M

Other non-operating income (expenses)

--5.00K

Income before tax

---16.70M

Income tax

---465.00K

Income after tax

---16.24M

Net income from continuous operations

---16.24M

Net income attributable to controlling interests

---16.24M

Net income attributable to common shareholders

---16.24M

Basic earnings per share

---5.30

Diluted earnings per share

---5.30

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

